Hepatosplenomegaly, pneumopathy, bone changes and fronto-temporal dementia: Niemann-Pick type B and SQSTM1-associated Paget's disease in the same individual.
Bone Marrow
/ pathology
Bone and Bones
/ pathology
Frontotemporal Dementia
/ complications
Hepatomegaly
/ complications
Humans
Male
Middle Aged
Niemann-Pick Disease, Type B
/ complications
Osteitis Deformans
/ complications
Sequestosome-1 Protein
/ genetics
Splenomegaly
/ complications
Tomography, X-Ray Computed
Acid sphingomyelinase
Interstitial pulmonary disease
Lysosomal storage disease
Niemann–Pick type B
Paget’s disease of bone
Journal
Journal of bone and mineral metabolism
ISSN: 1435-5604
Titre abrégé: J Bone Miner Metab
Pays: Japan
ID NLM: 9436705
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
18
02
2018
accepted:
19
04
2018
pubmed:
28
6
2018
medline:
7
5
2019
entrez:
28
6
2018
Statut:
ppublish
Résumé
Data from exome sequencing show that a proportion of individuals in whom a genetic disorder is suspected turn out to have not one, but two to four distinct ones. This may require an evolution in our diagnostic attitude towards individuals with complex disorders. We report a patient with splenomegaly, pneumopathy, bone changes and fronto-temporal dementia (FTD). "Sea-blue histiocytes" in his bone marrow pointed to a lysosomal storage disease. Homozygosity for a pathogenic mutation in the SMPD1 gene confirmed Niemann-Pick disease type B (NPD-B). Mild cognitive impairment and abnormal brain FDG PET were consistent with FTD. We initially tried to fit the skeletal and neurologic phenotype into the NPD-B diagnosis. However, additional studies revealed a pathogenic mutation in the SQSTM1 gene. Thus, our patient had two distinct diseases; NPD-B, and Paget's disease of bone with FTD. The subsequent finding of a mutation in SQSTM1 gene ended our struggle to explain the combination of findings by a singular "unifying" diagnosis and allowed us to make specific therapeutic decisions. SQSTM1 mutations have been reported in association with FTD, possibly because of defective autophagy. Bisphosphonates may be beneficial for PDB, but since they are known to inhibit acid sphingomyelinase activity, we refrained from using them in this patient. While the principle of looking for unifying diagnosis remains valid, physicians should consider the possibility of co-existing multiple diagnoses when clinical features are difficult to explain by a single one. Accurate diagnostic work-up can guide genetic counseling but also lead to better medical management.
Identifiants
pubmed: 29948344
doi: 10.1007/s00774-018-0932-1
pii: 10.1007/s00774-018-0932-1
doi:
Substances chimiques
SQSTM1 protein, human
0
Sequestosome-1 Protein
0
Types de publication
Case Reports
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
378-383Références
Am J Med Genet. 2002 Apr 15;109(1):42-51
pubmed: 11932991
Br J Radiol. 2002;75 Suppl 1:A2-12
pubmed: 12036828
J Inherit Metab Dis. 2003;26(8):775-85
pubmed: 14739682
Clin Sci (Lond). 2005 Sep;109(3):257-63
pubmed: 16104845
J Inherit Metab Dis. 2005;28(5):733-41
pubmed: 16151905
Pediatrics. 2008 Aug;122(2):e341-9
pubmed: 18625664
J Clin Invest. 1991 Sep;88(3):806-10
pubmed: 1885770
Angew Chem Int Ed Engl. 2009;48(41):7560-3
pubmed: 19746379
Cell Physiol Biochem. 2010;26(1):1-8
pubmed: 20501999
Autophagy. 2012 May 1;8(5):719-30
pubmed: 22647656
Biochim Biophys Acta. 2013 Jan;1831(1):223-7
pubmed: 22691949
J Bone Miner Res. 2012 Jul;27(7):1439-47
pubmed: 22706899
J Inherit Metab Dis. 2013 Jan;36(1):123-7
pubmed: 22718274
Neurology. 2012 Oct 9;79(15):1556-62
pubmed: 22972638
Immunol Invest. 2013;42(7):510-8
pubmed: 24004055
Exp Cell Res. 2014 Jul 1;325(1):27-37
pubmed: 24486447
Cell Death Differ. 2014 Jun;21(6):864-75
pubmed: 24488099
Mol Genet Metab. 2015 Sep-Oct;116(1-2):88-97
pubmed: 26049896
J Cell Biochem. 2016 Feb;117(2):289-99
pubmed: 26212817
J Endocrinol Invest. 2016 Mar;39(3):297-303
pubmed: 26219613
Lung. 2016 Aug;194(4):511-8
pubmed: 27164983
N Engl J Med. 2017 Jan 5;376(1):83-85
pubmed: 27959696
N Engl J Med. 2017 Jan 5;376(1):21-31
pubmed: 27959697
Mol Genet Metab. 2017 Jan - Feb;120(1-2):27-33
pubmed: 28164782
Eur Radiol. 1997;7(3):361-4
pubmed: 9087358